Terms: = Kidney tumors AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
57 results:
1. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
[TBL] [Abstract] [Full Text] [Related]
2. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas.
Zhang X; Wang C; Shen D
Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712
[TBL] [Abstract] [Full Text] [Related]
3. Harmful effect of repetitive intravenous iodinated contrast media administration on the long-term renal function of patients with early gastric cancer.
Koo JH; Lee M; Kim EH; Oh HJ; Lim JS; Hyung WJ; Yoon HI; Jung I; Chung YE
Sci Rep; 2023 Nov; 13(1):19448. PubMed ID: 37945805
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance of cdk6 expression in renal cell carcinoma treated by immune checkpoint plus tyrosine kinase inhibition.
Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J
Scand J Immunol; 2023 Oct; 98(4):e13304. PubMed ID: 37294700
[TBL] [Abstract] [Full Text] [Related]
5. AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway.
Peng BY; Singh AK; Chan CH; Deng YH; Li PY; Su CW; Wu CY; Deng WP
BMC Cancer; 2023 Jan; 23(1):1. PubMed ID: 36597025
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
Parmar A; Ghosh S; Sahgal A; Lalani AA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger C; Soulières D; Breau RH; Tanguay S; Kapoor A; Pouliot F; Bjarnason GA
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1763. PubMed ID: 36517084
[TBL] [Abstract] [Full Text] [Related]
7. A review on the role of PCGEM1 lncRNA in cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
[TBL] [Abstract] [Full Text] [Related]
8. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract] [Full Text] [Related]
9. Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.
Bai C; Zhang M; Zhang Y; He Y; Dou H; Wang Z; Wang Z; Li Z; Zhang L
Oxid Med Cell Longev; 2022; 2022():8494076. PubMed ID: 35707277
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ
Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.
Sager RA; Backe SJ; Ahanin E; Smith G; Nsouli I; Woodford MR; Bratslavsky G; Bourboulia D; Mollapour M
Nat Rev Urol; 2022 May; 19(5):305-320. PubMed ID: 35264774
[TBL] [Abstract] [Full Text] [Related]
12. Effects of
Chen Q; Fu Q; Pu L; Liu X; Liu Y
J Int Med Res; 2022 Feb; 50(2):3000605221075511. PubMed ID: 35118889
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of Renal Cell Carcinoma by Texture Analysis in Clinical Practice: A Six-Site, Six-Platform Analysis of Reliability.
Doshi AM; Tong A; Davenport MS; Khalaf AM; Mresh R; Rusinek H; Schieda N; Shinagare AB; Smith AD; Thornhill R; Vikram R; Chandarana H
AJR Am J Roentgenol; 2021 Nov; 217(5):1132-1140. PubMed ID: 33852355
[No Abstract] [Full Text] [Related]
14. Public attitudes towards screening for kidney cancer: an online survey.
Harvey-Kelly LLW; Harrison H; Rossi SH; Griffin SJ; Stewart GD; Usher-Smith JA
BMC Urol; 2020 Oct; 20(1):170. PubMed ID: 33115457
[TBL] [Abstract] [Full Text] [Related]
15. Cyclin Pathway Genomic Alterations Across 190,247 Solid tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
16. New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers.
Kotecha A; Raghavan D; Yadav SK; A Sule A; Arsene C
Int J Hematol; 2020 Oct; 112(4):477-486. PubMed ID: 32632822
[TBL] [Abstract] [Full Text] [Related]
17. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract] [Full Text] [Related]
18. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting cdk6 expression.
Guo Z; Jia H; Ge J
Hum Cell; 2020 Jul; 33(3):750-758. PubMed ID: 32277426
[TBL] [Abstract] [Full Text] [Related]
19. MiR-186 represses progression of renal cell cancer by directly targeting cdk6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract] [Full Text] [Related]
20. Esculetin inhibits proliferation, migration, and invasion of clear cell renal cell carcinoma cells.
Duan J; Shi J; Ma X; Xuan Y; Li P; Wang H; Fan Y; Gong H; Wang L; Pang Y; Pang S; Yan Y
Biomed Pharmacother; 2020 May; 125():110031. PubMed ID: 32164951
[TBL] [Abstract] [Full Text] [Related]
[Next]
